ProGlide®血管闭合器在大口径股动脉穿刺(>16Fr)中失败的相关因素分析
该回顾性研究纳入458例接受腹主动脉瘤、胸主动脉瘤、B型主动脉夹层修复或经导管主动脉瓣植入的患者,使用ProGlide®闭合大口径(16-26Fr)股动脉穿刺点。总体失败率为7.6%,外周动脉疾病史、股总动脉钙化、皮肤穿刺点深度≥33 mm、BMI≥28.7 kg/m²及鞘管尺寸≥19 Fr与失败显著相关。
要点
- ProGlide®用于大口径(16-26Fr)股动脉穿刺闭合时失败率约7.6%。
- 失败危险因素包括PAD史、CFA钙化、穿刺深度≥33 mm、BMI≥28.7 kg/m²、鞘管≥19 Fr。
- 术前评估上述因素有助于筛选适合患者并优化操作策略。
核心结论
- BMI、PAD史、股总动脉钙化、皮肤穿刺点深度及鞘管尺寸与ProGlide®失败显著相关。
研究设计与样本
- 回顾性研究,纳入458例接受腹主动脉瘤、胸主动脉瘤、B型主动脉夹层修复或经导管主动脉瓣植入的患者,使用ProGlide®闭合大口径(16-26Fr)股动脉穿刺点。
- 主要终点为器械失败,定义为无法实现股总动脉闭合、需外科修补、发生急性下肢缺血及血流动力学障碍,或随访期间出现需开放手术修复的延迟性假性动脉瘤。
主要发现
- 总体ProGlide®失败率为7.6%。
- 失败相关因素包括PAD史(p < .001)、股总动脉钙化(p < .001)、皮肤穿刺点深度≥33 mm(p < .001)、BMI≥28.7 kg/m²(p < .001)及鞘管尺寸≥19 Fr(p < .001)。
关键数值与推荐
- 鞘管尺寸≥19 Fr与失败显著相关(p < .001)。
- 皮肤穿刺点深度≥33 mm与失败显著相关(p < .001)。
- BMI≥28.7 kg/m²与失败显著相关(p < .001)。
- 股总动脉钙化与失败显著相关(p < .001)。
- PAD史与失败显著相关(p < .001)。
临床怎么用
- 对于存在PAD史、股总动脉钙化、皮肤穿刺深度≥33 mm、BMI≥28.7 kg/m²或使用鞘管≥19 Fr的患者,应谨慎选择ProGlide®并优化操作流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The ProGlide® vascular closure device (Abbott Vascular, Redwood City, CA, USA) is approved for the closure of arterial punctures (typically 5-21 Fr sheath; maximum outer diameter, 26 Fr). However, a failure rate of about 2-8% is reported. This study was conducted to analyse factors predisposing to failure when the devices were used for the closure of large hole (16-26 Fr) arteriotomies, and to determine the predictive cut off values of predisposing factors. METHODS: In this retrospective study, the ProGlide® device was used to achieve vascular access site closure in 458 patients undergoing repair of abdominal aortic aneurysm, thoracic aortic aneurysm, type B aortic dissection, or transcatheter aortic valve implantation. The primary endpoint was device failure, defined as inability to achieve common femoral artery (CFA) closure; successful repair, development of acute lower limb ischaemia and haemodynamic compromise; or delayed pseudoaneurysm formation during the follow up period, requiring open repair. RESULTS: Overall, ProGlide® failure occurred in 7.6% of cases. Factors that predisposed to failure included a history of peripheral arterial disease (PAD) (p < .001), the presence of CFA calcification (p < .001), the depth of the skin puncture site ≥ 33 mm (p < .001), body mass index (BMI) of ≥28.7 kg/m2 (p < .001), and use of sheath size ≥ 19 Fr (p < .001). CONCLUSION: Factors such as BMI, history of PAD, the presence of CFA calcification, the depth of the skin puncture site, and sheath size are significantly associated with ProGlide® failure. Hence, careful patient and device selection and operating procedure are paramount to achieve successful outcomes.
引用
- Chen IM, Lee TH, Chen PL, et al. Factors in ProGlide® Vascular Closure Failure in Sheath Arteriotomies Greater than 16 French. Eur J Vasc Endovasc Surg. 2019. PMID: 31500989. doi:10.1016/j.ejvs.2019.03.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。